Table 3.
Initiation and discontinuation of oral anticoagulation in the 12 months after the first visit during the study period in intervention and control arms
| Oral anticoagulation initiation |
Oral anticoagulation discontinuation |
|||
|---|---|---|---|---|
| Intervention | Control | Intervention | Control | |
| All | 17.7 (108/609) | 19.1 (118/619) | 6.3 (92/1459) | 7.2 (111/1540) |
| Age (y) | ||||
| 65–74 | 17.0 (44/259) | 16.5 (41/248) | 5.7 (30/528) | 7.8 (43/553) |
| 75–84 | 20.6 (45/218) | 21.8 (55/252) | 5.6 (37/655) | 6.4 (43/670) |
| ≥85 | 14.4 (19/132) | 18.5 (22/119) | 9.1 (25/276) | 7.9 (25/317) |
| Previous stroke | ||||
| No | 18.2 (91/501) | 19.0 (100/526) | 6.8 (76/1119) | 7.1 (83/1165) |
| Yes | 15.7 (17/108) | 19.4 (18/93) | 4.7 (16/340) | 7.5 (28/375) |
| CHA2DS2VASc score | ||||
| Low | 10.7 (3/28) | 25.8 (8/31) | 12.5 (3/24) | 10.3 (3/29) |
| Moderate | 20.4 (52/255) | 18.5 (44/238) | 7.4 (32/431) | 6.8 (29/424) |
| High | 16.3 (53/326) | 18.9 (66/350) | 5.7 (57/1004) | 7.3 (79/1087) |
Values are given as % (n/N).